Cardinal Health, Inc.(CAH)

New York Stock Exchange
Sector: Healthcare | Industry: Medical - Distribution
Cardinal Health, Inc. logo

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Latest News & Analysis

Cardinal Health financial analysis: strategic partnerships, OptumRx mitigation, and investment stability in healthcare.
Apr 9, 2025

Cardinal Health (CAH): Partnerships, Market Shifts, and Dividends

Cardinal Health navigates market shifts with strategic partnerships and a focus on dividend strength, despite OptumRx headwinds.

Read more →
Cardinal Health's financial strategy, new board members, trade tension responses, and dividend sustainability analysis.
Mar 20, 2025

Cardinal Health's Board, Trade Strategy & Financial Health: Investor Analysis

Analysis of Cardinal Health's board changes, trade strategy, and financial health. Key points include earnings acceleration, free cash flow concerns, and valuation.

Read more →
Cardinal Health strategic shift: New board members, focus on specialty markets, and financial challenges. Analyst outlook positive. Stay informed!
Mar 10, 2025

Cardinal Health (CAH): Board Changes Signal Strategic Shift

Cardinal Health's board gains healthcare analytics and cybersecurity expertise amid financial challenges. Strategic focus on specialty markets and dividend stability.

Read more →
Cardinal Health (CAH) stock analysis: Earnings, acquisitions, and market trends impacting CAH's performance in the healthcare sector.
Mar 3, 2025

Cardinal Health (CAH): Earnings, Acquisitions, and Market Analysis

Cardinal Health (CAH) navigates a dynamic healthcare market with strategic acquisitions and earnings acceleration, facing challenges from contract expiry and macro factors.

Read more →
Cardinal Health Strategic Growth: Navigating Market Headwinds and Capitalizing on Opportunities - A Comprehensive Financial Analysis.
Feb 28, 2025

Cardinal Health (CAH): Q2 Earnings, Acquisitions & Future Outlook

Cardinal Health (CAH) navigates headwinds with strategic acquisitions and a focus on specialty markets driving growth. Analyst upgrades and dividends reinforce stability.

Read more →
Cardinal Health Q2 2025 earnings analysis, strategic acquisitions, and market performance review.
Feb 27, 2025

Cardinal Health: Q2 Earnings, Strategic Moves & Market Analysis

Cardinal Health's Q2 earnings beat estimates, driven by strategic acquisitions and strong pharmaceutical segment performance. However, the OptumRx contract expiry poses challenges.

Read more →
Cardinal Health Q2 2025 earnings analysis: strategic acquisitions, dividend approval, and healthcare landscape navigation. Insights on financial performance, analyst sentiment, and future outlook.
Feb 26, 2025

Cardinal Health (CAH): Q2 Earnings, Acquisitions, and Analysis

Cardinal Health (CAH) navigates Q2 earnings beat amid OptumRx headwinds, strategic acquisitions, and cash flow concerns. Analysts raise targets, but challenges persist.

Read more →
Cardinal Health Q2 2025 earnings overview: revenue analysis, strategic acquisitions, and market outlook for investors. Stay informed about CAH performance.
Feb 21, 2025

Cardinal Health Q2 2025 Earnings Analysis: Key Takeaways and Strategic Implications

A comprehensive analysis of Cardinal Health's Q2 2025 earnings report, detailing segment performance, dividend news, strategic acquisitions, and market trends.

Read more →
Pharmaceutical products arranged on a clean surface.
Feb 18, 2025

Cardinal Health Q2 2025 Earnings: Key Takeaways and Impact

An in-depth update on CAH Q2 2025 earnings, strategic moves, and dividend news that shapes its market outlook.

Read more →